Consumer Product Safety
Viewpoints
Filter by:
California Prop 65 Reform?
August 12, 2013 | Blog | By Daniel Herling
California has a reputation for many things: 8th largest economy in the World; land of fruits and nuts and a state not being overly business friendly.
Read more
FDA Defines “Gluten-Free:” Consumers and Manufacturers Both Win
August 8, 2013 | Blog | By Howie Miller
On August 5, 2013 the FDA issued its final rule on the voluntary labeling of food gluten-free. This is good news for both consumers and manufacturers.
Read more
Six Flags Rollercoaster Tragedy Highlights Sometimes Confusing Nature of CPSC’s Jurisdiction
August 6, 2013 | Blog
When you board a ride at an amusement park, the question of who regulates the ride vs. the toy you just won is probably the last thing on your mind.
Read more
The Weakest Link -- Why Those Boilerplate Contract Clauses Matter
August 2, 2013 | Blog | By Daniel Herling
Contract clauses impacting risk assumption and risk transfer which are integral to the capturing of recall costs are often relegated to the “boiler plate” section of many Supply Agreements or are preprinted on the reverse side of POs that are often not sent by PDF or fax.
Read more
A Unique Approach to Youth Football Helmet Safety
August 1, 2013 | Blog
Starting in 2012, the U.S. Consumer Product Safety Commission (CPSC) teamed up with football helmet manufacturers, the National Football League (NFL), and others to eliminate the use of outdated football helmets and teach safer game play among youth football players.
Read more
The Food Court Kicks the Proper Use Of The Term “Natural” To FDA
July 13, 2013 | Blog | By Michelle Gillette
In what may be an indication of things to come, the Food Court (US District Court Northern District of California) has decided to ask FDA for guidance on what it wants on food labels.
Read more
The GMO Controversy Continues to Swirl
July 5, 2013 | Blog | By Michelle Gillette
Some are concerned that the potential health consequence of the use of genetically modified organisms in food is unknown because of the lack of long-term testing proving that it is safe.
Read more
Senate Confirms Two New CPSC Commissioners—What it Means for Them, You, and CPSC
July 3, 2013 | Blog
On June 27th, the U.S. Senate confirmed Marietta Robinson and Ann Marie Buerkle as new CPSC Commissioners. Robinson was first nominated in 2012 and participated in a hearing before the Senate Committee on Commerce, Science, and Transportation on May 10, 2012. Buerkle was nominated in late May of this year and confirmed by the Senate one month later without having a Senate hearing.
Read more
What Does The Word “Natural” Mean, Anyway?
June 12, 2013 | Blog | By Michelle Gillette
It’s 2 o’clock in the afternoon, you need a snack – maybe a granola bar, but which one? Does the package that boasts it is “100% Natural” win out over the one that is only “All Natural”?
Read more
CPSC Proposes Significant Amendments to Certificates of Conformity Rule
June 3, 2013 | Blog
The U.S. Consumer Product Safety Commission (“CPSC”) recently proposed to substantially alter its 2008 regulation governing the form and contents of certificates of compliance for consumer products.
Read more
Explore Other Viewpoints:
- AI: The Washington Report
- Antitrust
- Appellate
- Arbitration, Mediation & Alternate Dispute Resolution
- Artificial Intelligence
- Awards
- Bankruptcy & Restructuring
- California Land Use
- Class Action
- Complex Commercial Litigation
- Construction
- Consumer Product Safety
- Corporate Governance (ESG)
- Cross-Border Asset Recovery
- Debt Financing
- Direct Investing (M&A)
- Diversity
- EB-5 Financing
- Education & Nonprofits
- Election 2024
- Employment
- Energy & Sustainability
- Environmental (ESG)
- Environmental Enforcement Defense
- Environmental Law
- Environmental, Social, and Corporate Governance (ESG)
- FDA Regulatory
- False Claims Act
- Federal Circuit Appeals
- Financial Institution Litigation
- Government Law
- Growth Equity
- Health Care
- Health Care Compliance, Fraud and Abuse, & Regulatory Counseling
- Health Care Enforcement & Investigations
- Health Care Transactions
- Health Information Privacy & Security
- IP Due Diligence
- IPRs & Other Post Grant Proceedings
- Immigration
- Insolvency & Creditor Rights Litigation
- Institutional Investor Class Action Recovery
- Insurance & Financial Services
- Insurance Consulting & Risk Management
- Insurance and Reinsurance Problem-Solving & Dispute Resolution
- Intellectual Property
- Investment Funds
- Israel
- Licensing & Technology Transactions
- Life Sciences
- Litigation & Investigations
- M&A Litigation
- ML Strategies
- Medicare, Medicaid and Commercial Coverage & Reimbursement
- Mergers & Acquisitions
- Patent Litigation
- Patent Prosecution & Strategic Counseling
- Pharmacy Benefits and PBM Contracting
- Portfolio Companies
- Privacy & Cybersecurity
- Private Client
- Private Equity
- Pro Bono
- Probate & Fiduciary Litigation
- Products Liability & Complex Tort
- Projects & Infrastructure
- Public Finance
- Real Estate Litigation
- Real Estate Transactions
- Real Estate, Construction & Infrastructure
- Retail & Consumer Products
- Securities & Capital Markets
- Securities Litigation
- Social (ESG)
- Special Purpose Acquisition Company (SPACs)
- Sports & Entertainment
- State Attorneys General
- Strategic IP Monetization & Licensing
- Tax
- Technology
- Technology, Communications & Media
- Technology, Communications & Media Litigation
- Trade Secrets
- Trademark & Copyright
- Trademark Litigation
- Value-Based Care
- Venture Capital & Emerging Companies
- White Collar Defense & Government Investigations
- Women's Health and Technology